Gerresheimer AG (OTCMKTS:GRRMF) Sees Significant Drop in Short Interest

Gerresheimer AG (OTCMKTS:GRRMF) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 56,700 shares, a decrease of 70.4% from the May 15th total of 191,500 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 567.0 days.

Gerresheimer Price Performance

Shares of Gerresheimer stock remained flat at $55.75 on Friday. The company’s 50-day simple moving average is $66.39 and its 200 day simple moving average is $72.69. Gerresheimer has a 52 week low of $55.75 and a 52 week high of $114.50.

Wall Street Analysts Forecast Growth

GRRMF has been the topic of several recent analyst reports. Sanford C. Bernstein lowered shares of Gerresheimer to an “underperform” rating in a research note on Tuesday, June 3rd. Barclays reaffirmed an “overweight” rating on shares of Gerresheimer in a research note on Tuesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Gerresheimer from a “buy” rating to a “hold” rating in a research note on Tuesday, June 3rd.

Gerresheimer Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.